95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
23.44%
Revenue growth similar to NEM's 24.43%. Walter Schloss would see if both companies share industry tailwinds.
60.21%
Gross profit growth at 75-90% of NEM's 76.05%. Bill Ackman would demand operational improvements to match competitor gains.
-31.17%
Negative EBIT growth while NEM is at 84.37%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-33.15%
Negative operating income growth while NEM is at 82.02%. Joel Greenblatt would press for urgent turnaround measures.
-43.00%
Negative net income growth while NEM stands at 52.17%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-44.12%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-44.12%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.25%
Share reduction while NEM is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.01%
Diluted share change of 0.01% while NEM is zero. Bruce Berkowitz might see a minor difference that could widen over time.
0.19%
Maintaining or increasing dividends while NEM cut them. John Neff might see a strong edge in shareholder returns.
25.61%
OCF growth under 50% of NEM's 52.37%. Michael Burry might suspect questionable revenue recognition or rising costs.
-8.90%
Negative FCF growth while NEM is at 112.19%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
121.58%
10Y revenue/share CAGR above 1.5x NEM's 23.71%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
68.26%
5Y revenue/share CAGR above 1.5x NEM's 37.59%. David Dodd would look for consistent product or market expansions fueling outperformance.
35.77%
3Y revenue/share CAGR above 1.5x NEM's 17.03%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
177.46%
10Y OCF/share CAGR above 1.5x NEM's 95.81%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
139.14%
5Y OCF/share CAGR above 1.5x NEM's 48.61%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
62.38%
3Y OCF/share CAGR above 1.5x NEM's 33.98%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
38.48%
Below 50% of NEM's 3977.30%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
12.23%
Below 50% of NEM's 77.09%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-70.02%
Negative 3Y CAGR while NEM is 2213.99%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
63.53%
10Y equity/share CAGR above 1.5x NEM's 26.98%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
34.54%
Positive 5Y equity/share CAGR while NEM is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
15.29%
Positive short-term equity growth while NEM is negative. John Neff sees a strong advantage in near-term net worth buildup.
235.15%
Below 50% of NEM's 924.41%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
103.88%
5Y dividend/share CAGR 1.25-1.5x NEM's 76.41%. Bruce Berkowitz verifies that high dividend hikes remain sustainable, not a sign of over-distribution.
21.23%
Our short-term dividend growth is positive while NEM cut theirs. John Neff views it as a comparative advantage in shareholder returns.
-47.47%
Firm’s AR is declining while NEM shows 8.42%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
0.52%
Asset growth above 1.5x NEM's 0.31%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
0.24%
Under 50% of NEM's 0.71%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-8.70%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-11.40%
We cut SG&A while NEM invests at 13.27%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.